DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 2Dr. Reddy's Laboratories
02 6Strides Pharma Science
03 1Acella Pharmaceuticals
04 13Actavis Inc
05 1Aeon Formulations Private Limited
06 4Ajanta Pharma Limited
07 11Alembic Pharmaceuticals Limited
08 5Amneal Pharmaceuticals
09 4Apotex Inc
10 1Aurobindo Pharma Limited
11 7Avet Pharmaceuticals
12 2Bausch & Lomb Incorporated
13 2Changzhou Pharmaceutical Factory
14 9Chartwell Pharmaceuticals llc
15 1DenMat Dental
16 1ENDO OPERATIONS
17 5Epic Pharma. LLC.
18 2Fresenius Kabi USA
19 1GALDERMA LABS LP
20 1GLAND PHARMA LIMITED
21 1Galderma
22 2HALSEY
23 3HEATHER
24 8Hikma Pharmaceuticals
25 1Holden Medical Laboratories Pvt. Ltd
26 2Impax Laboratories
27 3Interpharm
28 2JAMP PHARMA
29 1KINDOS
30 1LABORATOIRE RIVA INC.
31 1LARKEN LABS
32 11Lupin Ltd
33 1MANTRA PHARMA INC
34 2MS Pharma
35 10Mayne Pharma
36 3Mutual Pharmaceutical Company, Inc.
37 1Neopharma
38 2Nesher Pharmaceuticals USA LLC
39 3Nostrum Laboratories
40 1Novel Laboratories, Inc.
41 1ORYZA
42 1PENDOPHARM DIVISION OF DE PHARMASCIENCE INC
43 1PRO DOC LIMITEE
44 2PVT FORM
45 1Pantex Holland
46 2Par Pharmaceutical
47 4Pelcoat Formulations
48 5Pfizer Inc
49 1Pharmanovia A/S
50 1Pharmaris
51 2Pharmascience Inc.
52 1Pliva Hrvatska
53 1Praxgen
54 3Prinston
55 2Qilu Animal Health Products
56 2Quad Pharma
57 1RACHELLE
58 1Ratiopharm GmbH
59 7Rising Pharmaceuticals Inc
60 2SANIS HEALTH INC
61 3SUPERPHARM
62 2Shijiazhuang Fengqiang Animal Pharmaceutical Co., Ltd
63 2Slate Run Pharmaceuticals
64 6Sun Pharmaceutical Industries Limited
65 5Teva Pharmaceutical Industries
66 2Torrent Pharmaceuticals Limited
67 2Unichem Laboratories Limited
68 2V-Ensure
69 2Viatris
70 1Virjo Healthcare
71 4Warner Chilcott Company, LLC
72 2West-ward Pharmaceutical Corp
73 2Zhejiang Yongtai Technology
74 3Zydus Lifesciences
75 5Zydus Pharmaceuticals
01 9CAPSULE
02 1CAPSULE, COATED PELLETS;ORAL
03 5CAPSULE, DELAYED RELEASE;ORAL
04 53CAPSULE;ORAL
05 1CONCENTRATE FOR SOLUTION FOR INFUSION
06 5Capsule
07 1Capsule IP
08 4Enteric Coated Pellets
09 22INJECTABLE;INJECTION
10 1Inection
11 2Injectable; Injection
12 1Injection
13 1ORAL SUSPENSION
14 1Oral Solution/Suspension
15 2Powder
16 1SYSTEM, EXTENDED RELEASE;PERIODONTAL
17 9TABLET
18 42TABLET, DELAYED RELEASE;ORAL
19 57TABLET;ORAL
20 2Tablet
21 1WSP / Premix
22 1Water Soluble Powder
01 101DISCN
02 6Generic
03 2Prescription
04 80RX
05 33Blank
01 2ACTICLATE
02 1ACTICLATE CAP
03 1APO-DOXY CAP 100MG
04 1APO-DOXY TABS 100MG
05 1ATRIDOX
06 9DORYX
07 2DORYX MPC
08 1DOXIEONnn
09 1DOXY 100
10 1DOXY 200
11 3DOXY-LEMMON
12 1DOXYCHEL HYCLATE
13 1DOXYCIN TAB 100MG
14 7DOXYCYCLINE
15 1DOXYCYCLINE CAPSULES
16 147DOXYCYCLINE HYCLATE
17 1DOXYCYCLINE TABLETS
18 1DOXYTAB
19 1Doxyferm
20 1Doxyline-100
21 1Doxyline-200
22 2Doxy®
23 1Gendox 10/5
24 1JAMP DOXYCYCLINE
25 1JAMP DOXYCYCLINE CAPSULES
26 1LYMEPAK
27 1M-DOXYCYCLINE
28 1Neocycline
29 3PERIOSTAT
30 2PMS-DOXYCYCLINE
31 1PRZ-DOXYCYCLINE
32 2TEVA-DOXYCYCLINE
33 1VIBRA-TABS
34 4VIBRAMYCIN
35 1Vibranord
36 15Blank
01 15Canada
02 4China
03 14India
04 2Jordan
05 1Netherlands
06 2Sweden
07 1U.A.E
08 183USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 75MG BASE
Packaging :
Approval Date : 2017-06-14
Application Number : 208765
Regulatory Info : RX
Registration Country : USA
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 1982-03-29
Application Number : 62337
Regulatory Info : DISCN
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 2017-06-14
Application Number : 208765
Regulatory Info : RX
Registration Country : USA
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1982-03-29
Application Number : 62337
Regulatory Info : DISCN
Registration Country : USA
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1986-04-07
Application Number : 62538
Regulatory Info : DISCN
Registration Country : USA
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 1982-01-01
Application Number : 61717
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1982-01-01
Application Number : 61717
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1982-01-01
Application Number : 62031
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ATRIDOX
Dosage Form : SYSTEM, EXTENDED RELEASE;PERIODONTAL
Dosage Strength : 50MG
Packaging :
Approval Date : 1998-09-03
Application Number : 50751
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PERIOSTAT
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1998-09-30
Application Number : 50744
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PERIOSTAT
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2001-02-02
Application Number : 50783
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DORYX
Dosage Form : CAPSULE, DELAYED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1985-07-22
Application Number : 50582
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DORYX
Dosage Form : CAPSULE, DELAYED RELEASE;ORAL
Dosage Strength : EQ 75MG BASE
Packaging :
Approval Date : 2001-08-13
Application Number : 50582
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DORYX
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : EQ 75MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2005-05-06
Application Number : 50795
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DORYX
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2005-05-06
Application Number : 50795
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DORYX
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2008-06-20
Application Number : 50795
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DORYX
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : EQ 80MG BASE
Packaging :
Approval Date : 2013-04-11
Application Number : 50795
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DORYX
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2013-04-11
Application Number : 50795
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DORYX
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2014-12-19
Application Number : 50795
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DORYX MPC
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : EQ 60MG BASE
Packaging :
Approval Date : 2016-05-20
Application Number : 50795
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DORYX MPC
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : EQ 120MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2016-05-20
Application Number : 50795
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VIBRAMYCIN
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 50007
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : VIBRAMYCIN
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1982-01-01
Application Number : 50007
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VIBRAMYCIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 200MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 50442
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VIBRAMYCIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 100MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 50442
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VIBRA-TABS
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 50533
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXYCHEL HYCLATE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 100MG BASE/VIAL
Packaging :
Approval Date : 1982-01-01
Application Number : 61953
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
